Landmark Bio is a pioneering company based in Watertown, Massachusetts, that specializes in translating groundbreaking research into life-changing medicines. Established in 2021, the company offers development, manufacturing, and regulatory capabilities to assist early-stage life science innovators in advancing therapies from the laboratory to clinical settings. Landmark Bio uniquely combines expertise from industry, academia, and research hospitals to accelerate innovation in the life sciences sector, focusing on the development of advanced therapies, particularly in the Cell and Gene Therapy space.